<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE334nnn/GSE334206/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Other</omics_type><species>Homo sapiens</species><gds_type>Other</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE334206</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>STK25 m6A modification regulates CD4+ T cell glycolysis mediated immune imbalance in systemic lupus erythematosus</name><description>Systemic lupus erythematosus (SLE) is a complex autoimmune disease with an incompletely understood pathogenesis. N6-methyladenosine (m6A) has been implicated in immune regulation and disease progression, yet its role in disrupting immune homeostasis in SLE, particularly in CD4+ T-cell differentiation, remains poorly understood. In the present study, m6A-modified RNA immunoprecipitation sequencing (m6A-seq) and RNA sequencing (RNA-seq) of peripheral blood mononuclear cells from patients with SLE identified serine/threonine protein kinase 25 (STK25) as a candidate gene exhibiting abnormal m6A modification, and its expression was subsequently validated using reverse transcription-quantitative (RT-q)PCR. CD4+ T cells isolated from MRL/lupus-prone mice underwent lentiviral-mediated STK25 knockdown, and glycolytic activity was evaluated through measuring glucose uptake and lactate production. Western blotting and RT-qPCR demonstrated that STK25 knockdown reduced the expression of glycolysis-associated genes (glucose transporter 1, hexokinase 2, pyruvate kinase M2 and lactate dehydrogenase A) and the Treg-specific transcription factor Foxp3, while increasing the expression of the Th17- and Th2-associated transcription factors, RORγt and Gata3. Flow cytometry further confirmed enhanced differentiation of Th17 and Th2 cells accompanied by a reduction in Treg cells, indicating disruption of immune homeostasis. Collectively, these findings suggested that aberrant m6A modification contributes to the downregulation of STK25 expression, thereby promoting glycolytic reprogramming and CD4+ T-cell subset imbalance in SLE. STK25 may therefore represent a potential therapeutic target for restoring immune homeostasis in SLE.</description><dates><publication>2026/06/04</publication></dates><accession>GSE334206</accession><cross_references><GSM>GSM9783360</GSM><GSM>GSM9783364</GSM><GSM>GSM9783353</GSM><GSM>GSM9783363</GSM><GSM>GSM9783352</GSM><GSM>GSM9783351</GSM><GSM>GSM9783362</GSM><GSM>GSM9783361</GSM><GSM>GSM9783350</GSM><GSM>GSM9783346</GSM><GSM>GSM9783357</GSM><GSM>GSM9783356</GSM><GSM>GSM9783355</GSM><GSM>GSM9783354</GSM><GSM>GSM9783365</GSM><GSM>GSM9783349</GSM><GSM>GSM9783348</GSM><GSM>GSM9783359</GSM><GSM>GSM9783358</GSM><GSM>GSM9783347</GSM><GPL>24676</GPL><GSE>334206</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>